ORMDL3 and asthma: Regarding the de novo synthetic pathway of sphingolipids, genome-wide association studies revealed that single nucleotide polymorphism (SNP) of oroscomucoid-like protein 3 (ORMDL3) at the 17q21 locus increased the risk of asthma [20–22].